Literature DB >> 656287

The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.

B F Johnson, J O'Grady, C Bye.   

Abstract

1 The influence of particle size on absorption of digoxin was studied in ten healthy volunteers who received 0.5 mg digoxin as two standard Lanoxin tablets, or tablets containing micronized digoxin or large particle size digoxin. Tablets were given 30 min after 15 mg propantheline, 10 mg metoclopramine or a placebo tablet, and following an overnight fast. 2 The overall mean cumulative 4 day urinary excretion of digoxin was significantly lower (P less than 0.01) after large particle size digoxin than after standard or micronized digoxin. Mean cumulative urinary excretion following large particle size digoxin was reduced when administered after metoclopramide and increased after propantheline, the difference between these two treatments being significant (P less than 0.05). There was a significantly lower (P less than 0.05) overall mean cumulative excretion following standard by comparison with micronized digoxin. However, by comparison with placebo, neither metoclopramide nor propantheline significantly altered mean cumulative excretion after standard or micronized digoxin. Propantheline and metoclopramide affect absorption of digoxin from formulations of large particle size and slow dissolution rate only.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656287      PMCID: PMC1429356          DOI: 10.1111/j.1365-2125.1978.tb01657.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  A clinical evaluation of a new anticholinergic drug, pro-banthine.

Authors:  I R SCHWARTZ; E LEHMAN; R OSTROVE; J M SEIBEL
Journal:  Gastroenterology       Date:  1953-11       Impact factor: 22.682

2.  Effect of particle size on the bioavailability of digoxin.

Authors:  A J Jounela; P J Pentikäinen; A Sothmann
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

3.  Altered absorption of digoxin in patients given propantheline and metoclopramide.

Authors:  W G Thompson
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

4.  Altered absorption of digoxin in patients given propantheline and metoclopramide.

Authors:  V Manninen; A Apajalahti; J Melin; M Karesoja
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

5.  Influence of dispersion method on dissolution rate and bioavailability of digoxin from triturations and compressed tablets II.

Authors:  N Shah; R Pytelewski; H Eisen; C I Jarowski
Journal:  J Pharm Sci       Date:  1974-03       Impact factor: 3.534

6.  The effect of particle size on the absorption of digoxin.

Authors:  T R Shaw; J E Carless
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

7.  Action of metoclopramide on gastric emptying and small bowel transit time.

Authors:  W B James; R Hume
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

8.  The effect of particle size reduction on digoxin crystal properties.

Authors:  A T Florence; E G Salole; J B Stenlake
Journal:  J Pharm Pharmacol       Date:  1974-06       Impact factor: 3.765

9.  The action of "metoclopramide" on gastric emptying: a radiological assessment.

Authors:  G R Margieson; W A Sorby; H B Williams
Journal:  Med J Aust       Date:  1966-12-31       Impact factor: 7.738

10.  Gastrointestinal effects of metoclopramide in man. In vitro experiments with human smooth muscle preparations.

Authors:  M Eisner
Journal:  Br Med J       Date:  1968-12-14
View more
  7 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  An integrated model for determining causes of poor oral drug absorption.

Authors:  L X Yu
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

4.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 5.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 6.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

7.  Pharmacological attempts to improve the bioavailability of oral etoposide.

Authors:  S P Joel; P I Clark; L Heap; L Webster; S Robbins; H Craft; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.